Physician profile
Alpha B Journal
NPI 1396162889
$1,458.66
in general payments reported to CMS, 2019-2025
16 companies · $248 in 2025
The $248 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $283 · 2022: $360 · 2023: $320 · 2024: $247 · 2025: $248.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $816.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $815.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi Pasteur INC. | $248.37 | 2023-2025 | |
| Cranial Technologies, INC | $218.56 | 2021-2025 | Doc Band |
| Merck Sharp & Dohme LLC | $199.21 | 2022-2025 | Gardasil 9, Vaxelis, Rotateq |
| Takeda Pharmaceuticals U.S.A., INC. | $151.85 | 2021-2022 | |
| Pfizer INC. | $148.50 | 2021-2023 | |
| Corium, LLC | $147.09 | 2022 | |
| Kaleo, INC. | $80.48 | 2021-2024 | Auvi-Q |
| Glaxosmithkline, LLC. | $63.75 | 2022-2023 | Bexsero |
| Seqirus USA INC | $34.08 | 2022-2025 | Flucelvax |
| Phadia US INC. | $33.30 | 2022-2025 | Immunocap |
| Alk-Abello, INC | $29.74 | 2025 | Neffy |
| Alexion Pharmaceuticals, INC. | $27.32 | 2024 | Koselugo |
| Ultragenyx Pharmaceutical INC. | $21.01 | 2021 | |
| Verrica Pharmaceuticals INC. | $19.35 | 2023 | Ycanth |
| Sobi, INC | $18.38 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Adlon Therapeutics L.P. | $17.67 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alpha Journal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.